Heart disease is the leading cause of death for women, and the pathophysiology, prevention strategies, screening, and treatments are often different from men. This session will discuss differences and similarities in heart disease between women and men and offer recommendations for prevention, evaluation and treatment.
After implementing current guideline-directed medical management, there is still urgency to address residual cardiovascular risk. Among the drivers of residual cardiovascular risk, inflammation has generated considerable interest, first based on preclinical and biomarker studies in humans. More recently, translation has inspired clinical trials in this domain. This presentation will consider inflammation as a process that links traditional and nontraditional risk factors to atherothrombotic events.